Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrolamellar hepatoma.

M T Ruffin1

  • 1Department of Family Practice and Community Health, University of Minnesota, Minneapolis.

The American Journal of Gastroenterology
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Fibrolamellar hepatocellular carcinoma (FLHC) is a rare cancer subtype predominantly found in the United States. This study reviews FLHC cases, comparing them to hepatocellular carcinoma (HCC) to evaluate FLHC as a distinct entity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2014
Same author

Development of exchange lists for Mediterranean and Healthy Eating diets: implementation in an intervention trial.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2013
Same author

High vegetable and fruit diet intervention in premenopausal women with cervical intraepithelial neoplasia.

Journal of the American Dietetic Association·2001
Same author

Do antioxidants still have a role in the prevention of human cancer?

Current oncology reports·2001
Same author

Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Prevention of cervix cancer.

Critical reviews in oncology/hematology·2000

Area of Science:

  • Hepatobiliary cancers
  • Oncology
  • Gastroenterology

Background:

  • Primary hepatocellular carcinoma (HCC) has a high global incidence and poor prognosis, representing 2% of US cancers.
  • Fibrolamellar hepatocellular carcinoma (FLHC) is a distinct subtype of HCC, primarily reported in the United States.

Observation:

  • This study reports five FLHC cases from the University of Minnesota's 17-year experience.
  • The reported FLHC cases were compared with existing literature on FLHC and HCC.

Findings:

  • The findings aim to evaluate fibrolamellar hepatocellular carcinoma (FLHC) as a distinct entity separate from primary hepatocellular carcinoma (HCC).
  • Literature review supports the unique characteristics of FLHC compared to HCC.

Implications:

Related Experiment Videos

  • Understanding FLHC as a distinct entity is crucial for accurate diagnosis and targeted treatment strategies.
  • Further research into FLHC pathogenesis and clinical behavior is warranted to improve patient outcomes.